Patent holdings for IPC class A61K 31/675

Total number of patents in this class: 4593

10-year publication summary

341
361
379
379
375
494
490
455
420
182
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2026
124
Antecip Bioventures II LLC
327
101
Iovance Biotherapeutics, Inc.
337
67
Merck Sharp & Dohme LLC
3739
46
Immunomedics, Inc.
267
42
The Regents of the University of California
19803
40
The Johns Hopkins University
5637
37
Novartis AG
10927
36
Bristol-myers Squibb Company
4897
36
Rigel Pharmaceuticals, Inc.
541
35
Psilo Scientific Ltd.
54
35
The United States of America, as represented by the Secretary, Department of Health and Human Services
2837
27
Achillion Pharmaceuticals, Inc.
164
23
Cipla Limited
467
23
Centre National de La Recherche Scientifique
10311
21
Turtle Bear Holdings, LLC
88
20
Allergan, Inc.
2359
19
Pharmacyclics LLC
238
18
Ascentage Pharma (Suzhou) Co., Ltd.
174
18
Compass Pathfinder Limited
98
18
Other owners 3807